Loading...

Uma Mahadevan, MD

TitleProfessor
InstitutionUniversity of California San Francisco
DepartmentMedicine
Address1701 Divisadero
San Francisco CA 94115
Phone415-502-4444
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    SUNY BrooklynM.D.1995
    Mount Sinai School of MedicineInternal Medicine1998
    University of California, San FranciscoGastroenterology2001
    Mayo Clinic, Rochester, MNInflammatory Bowel Disease2001
    Collapse Awards and Honors
    2008  - 2015Best Doctors in America

    Collapse Overview 
    Collapse Overview
    Dr. Mahadevan completed a medical degree at the State University of New York in Brooklyn. She completed residency in internal medicine at Mount Sinai Medical Center in New York, a fellowship in gastroenterology at the University of California, San Francisco (UCSF) and a fellowship in inflammatory bowel disease (IBD) at the Mayo Clinic in Rochester, Minnesota. Dr. Mahadevan currently serves as Professor of Medicine at UCSF, Medical Director of the UCSF Center for Colitis and Crohn’s Disease and Director of the IBD Fellowship. She is the Ambulatory Clinical Services Chief for Gastroenterology.

    Certified by the American Board of Internal Medicine as a Diplomate in internal medicine and gastroenterology, Dr. Mahadevan is a fellow of the American Gastroenterological Association, for whom she is Chair for the Clinical Immunology, Microbiology and Inflammatory Bowel Disease (IMIBD) Section and co-director of the 2017 Post-Graduate Course. She is also a fellow of the American College of Gastroenterology for whom she was Chair of IBD for the 2017 ACG/World Congress course and a member of the Educational Affairs Committee. She is currently Chair of the Crohn's Colitis Foundation Clinical Research Grants committee and a member of the CCF National Scientific Advisory Committee. She was elected to the International Organization of IBD (IOIBD) in 2018.

    Dr. Mahadevan is an special section editor for Gastroenterology and an editorial board member and reviewer for several other journals. She was the editor of a special issue on IBD for 2017. Dr. Mahadevan has published original articles, abstracts, editorials, and invited reviews in such peer-reviewed journals as Gastroenterology, Gut, American Journal of Gastroenterology and Inflammatory Bowel Diseases along with several book chapters.

    Dr. Mahadevan specializes in the treatment of ulcerative colitis, Crohn’s disease, and pouchitis. She has a particular interest in pregnancy and fertility in IBD, nutritional therapies for IBD, as well as in clinical trials of experimental therapy for both ulcerative colitis and Crohn’s disease. Her current projects include a national prospective registry of pregnancy outcomes and drug safety in women with IBD on immunosuppressive and biologic medications (PIANO), clinical trials in biologic therapy for IBD, and microbiome, environmental and dietary changes among patients with IBD.


    Collapse Research 
    Collapse Research Activities and Funding
    Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes (PIANO)
    Crohn's Colitis Foundation Jun 30, 2016 - Jun 30, 2019
    Role: Primary Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Global Health
    Collapse Websites
    Collapse In The News
    Collapse Faculty Mentoring
    Collapse Featured Presentations
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Mao EJ, Mahadevan U. The Debate is Over: Continue Anti-Tumor Necrosis Factor Therapy Throughout Pregnancy. Am J Gastroenterol. 2018 Oct 18. PMID: 30337704.
      View in: PubMed
    2. Mao EJ, Sheibani S, Martin C, Bloomfeld RS, Isaacs K, Saha S, Mahadevan U. Preventive Health Care Among Postpartum Women With Inflammatory Bowel Disease: Results From the PIANO Registry. Inflamm Bowel Dis. 2018 Sep 25. PMID: 30256951.
      View in: PubMed
    3. Kattah MG, Milush JM, Burt T, McCabe RP, Whang MI, Ma A, Mahadevan U. Correction: Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants. Clin Transl Gastroenterol. 2018 Jul 31; 9(7):172. PMID: 30065242.
      View in: PubMed
    4. Lichtenstein GR, Feagan BG, Mahadevan U, Salzberg BA, Langholff W, Morgan GJ, Safdi M, Nissinen R, Taillard F, Sandborn WJ, Cohen RD. Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report. Am J Gastroenterol. 2018 Jul 19. PMID: 30022113.
      View in: PubMed
    5. Mahadevan U, Dubinsky MC, Su C, Lawendy N, Jones TV, Marren A, Zhang H, Graham D, Clowse MEB, Feldman SR, Baumgart DC. Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis. Inflamm Bowel Dis. 2018 Jul 02. PMID: 29982686.
      View in: PubMed
    6. Matro R, Martin CF, Wolf D, Shah SA, Mahadevan U. Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development. Gastroenterology. 2018 May 29. PMID: 29857090.
      View in: PubMed
    7. Kattah MG, Milush JM, Burt T, McCabe RP, Whang MI, Ma A, Mahadevan U. Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants. Clin Transl Gastroenterol. 2018 Apr 03; 9(4):143. PMID: 29618720.
      View in: PubMed
    8. Mahadevan U, Silverberg MS. Inflammatory Bowel Disease-Gastroenterology Diamond Jubilee Review. Gastroenterology. 2018 Mar 15. PMID: 29550591.
      View in: PubMed
    9. Beaulieu DB, Ananthakrishnan AN, Martin C, Cohen RD, Kane SV, Mahadevan U. Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):99-105. PMID: 28870657.
      View in: PubMed
    10. Bengtson MB, Aamodt G, Mahadevan U, Vatn MH. Inadequate Gestational Weight Gain, the Hidden Link Between Maternal IBD and Adverse Pregnancy Outcomes: Results from the Norwegian Mother and Child Cohort Study. Inflamm Bowel Dis. 2017 07; 23(7):1225-1233. PMID: 28452861.
      View in: PubMed
    11. Mahadevan U, Vermeire S, Lasch K, Abhyankar B, Bhayat F, Blake A, Dubinsky M. Editorial: vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum? Authors' reply. Aliment Pharmacol Ther. 2017 05; 45(9):1284. PMID: 28370036.
      View in: PubMed
    12. Mahadevan U. How to Get an Education in Inflammatory Bowel Disease During Fellowship: Expectations and Realities. Gastroenterology. 2017 Jun; 152(8):1813-1816. PMID: 28461195.
      View in: PubMed
    13. Bengtson MB, Martin CF, Aamodt G, Vatn MH, Mahadevan U. Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort. Dig Dis Sci. 2017 08; 62(8):2063-2069. PMID: 28332106.
      View in: PubMed
    14. Mahadevan U, Vermeire S, Lasch K, Abhyankar B, Bhayat F, Blake A, Dubinsky M. Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease. Aliment Pharmacol Ther. 2017 04; 45(7):941-950. PMID: 28169436.
      View in: PubMed
    15. Colombel JF, Mahadevan U. Inflammatory Bowel Disease 2017: Innovations and Changing Paradigms. Gastroenterology. 2017 02; 152(2):309-312. PMID: 27960091.
      View in: PubMed
    16. Mahadevan U, McConnell RA, Chambers CD. Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease. Gastroenterology. 2017 02; 152(2):451-462.e2. PMID: 27769809.
      View in: PubMed
    17. Mar JS, LaMere BJ, Lin DL, Levan S, Nazareth M, Mahadevan U, Lynch SV. Disease Severity and Immune Activity Relate to Distinct Interkingdom Gut Microbiome States in Ethnically Distinct Ulcerative Colitis Patients. MBio. 2016 08 16; 7(4). PMID: 27531910; PMCID: PMC4992973.
    18. McConnell RA, Mahadevan U. The Birds, the Bees, and Inflammatory Bowel Disease: Preconception Care in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2016 Sep; 14(9):1293-5. PMID: 27264392.
      View in: PubMed
    19. McConnell RA, Mahadevan U. Pregnancy and the Patient with Inflammatory Bowel Disease: Fertility, Treatment, Delivery, and Complications. Gastroenterol Clin North Am. 2016 06; 45(2):285-301. PMID: 27261899.
      View in: PubMed
    20. Cohan JN, Ozanne EM, Sewell JL, Hofer RK, Mahadevan U, Varma MG, Finlayson E. A Novel Decision Aid for Surgical Patients with Ulcerative Colitis: Results of a Pilot Study. Dis Colon Rectum. 2016 Jun; 59(6):520-8. PMID: 27145309.
      View in: PubMed
    21. Kathpalia P, Kane S, Mahadevan U. Detectable Drug Levels in Infants Exposed to Biologics: So What? Gastroenterology. 2016 07; 151(1):25-6. PMID: 27215654.
      View in: PubMed
    22. Carlucci JG, Halasa N, Creech CB, Dulek DE, Gómez-Duarte OG, Nelson GE, Talbot HK, Scalise ML, Scott PL, Mahadevan U, Beaulieu DB. Vertical Transmission of Histoplasmosis Associated With Anti-Tumor Necrosis Factor Therapy. J Pediatric Infect Dis Soc. 2016 Jun; 5(2):e9-e12. PMID: 27012275.
      View in: PubMed
    23. Sheibani S, Cohen R, Kane S, Dubinsky M, Church JA, Mahadevan U. The Effect of Maternal Peripartum Anti-TNFa Use on Infant Immune Response. Dig Dis Sci. 2016 06; 61(6):1622-7. PMID: 26725061.
      View in: PubMed
    24. McConnell RA, Mahadevan U. Use of Immunomodulators and Biologics Before, During, and After Pregnancy. Inflamm Bowel Dis. 2016 Jan; 22(1):213-23. PMID: 26444103.
      View in: PubMed
    25. Nguyen GC, Seow CH, Maxwell C, Huang V, Leung Y, Jones J, Leontiadis GI, Tse F, Mahadevan U, van der Woude CJ. The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. Gastroenterology. 2016 Mar; 150(3):734-757.e1. PMID: 26688268.
      View in: PubMed
    26. Mahadevan U, Matro R. In Reply. Obstet Gynecol. 2015 Nov; 126(5):1109. PMID: 26488508.
      View in: PubMed
    27. Clowse ME, Wolf DC, Förger F, Cush JJ, Golembesky A, Shaughnessy L, De Cuyper D, Mahadevan U. Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol. J Rheumatol. 2015 Dec; 42(12):2270-8. PMID: 26523031.
      View in: PubMed
    28. Mahadevan U, Matro R. Care of the Pregnant Patient With Inflammatory Bowel Disease. Obstet Gynecol. 2015 Aug; 126(2):401-12. PMID: 26241432.
      View in: PubMed
    29. Kattah MG, Mahadevan U. Confocal laser endomicroscopy for membrane-bound tumor necrosis factor predicts response to therapy in Crohn's disease. Gastroenterology. 2015 May; 148(5):1067-9. PMID: 25824357.
      View in: PubMed
    30. Kavanaugh A, Cush JJ, Ahmed MS, Bermas BL, Chakravarty E, Chambers C, Clowse M, Curtis JR, Dao K, Hankins GD, Koren G, Kim SC, Lapteva L, Mahadevan U, Moore T, Nolan M, Ren Z, Sammaritano LR, Seymour S, Weisman MH. Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases. Arthritis Care Res (Hoboken). 2015 Mar; 67(3):313-25. PMID: 25385050.
      View in: PubMed
    31. Huang VW, Mahadevan U. A measured approach to Crohn's therapy: check levels and save. Gastroenterology. 2014 Nov; 147(5):1174-5. PMID: 25240163.
      View in: PubMed
    32. Lin K, Mahadevan U. Pharmacokinetics of biologics and the role of therapeutic monitoring. Gastroenterol Clin North Am. 2014 Sep; 43(3):565-79. PMID: 25110259.
      View in: PubMed
    33. Kattah MG, Mahadevan U. Insights into the molecular pathophysiology of inflammatory bowel disease: ATG16L1 suppresses nod-driven inflammation. Gastroenterology. 2014 Aug; 147(2):528-30. PMID: 24953625.
      View in: PubMed
    34. Hassid B, Mahadevan U. The use of biologic therapy in pregnancy: a gastroenterologist's perspective. Curr Opin Rheumatol. 2014 May; 26(3):347-53. PMID: 24625373.
      View in: PubMed
    35. Hwang C, Ross V, Mahadevan U. Popular exclusionary diets for inflammatory bowel disease: the search for a dietary culprit. Inflamm Bowel Dis. 2014 Apr; 20(4):732-41. PMID: 24562173.
      View in: PubMed
    36. Shah S, Terdiman J, Gundling K, Mahadevan U. Immunoglobulin therapy for refractory Crohn's disease. Therap Adv Gastroenterol. 2014 Mar; 7(2):99-102. PMID: 24587823; PMCID: PMC3903086.
    37. Ng SW, Mahadevan U. My treatment approach to management of the pregnant patient with inflammatory bowel disease. Mayo Clin Proc. 2014 Mar; 89(3):355-60. PMID: 24582194.
      View in: PubMed
    38. Lin KK, Mahadevan U. Etrolizumab: anti-ß7-a novel therapy for ulcerative colitis. Gastroenterology. 2014 Jan; 146(1):307-9. PMID: 24269566.
      View in: PubMed
    39. Truta B, Li DX, Mahadevan U, Fisher ER, Chen YY, Grace K, Velayos F, Terdiman JP. Serologic markers associated with development of Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis. Dig Dis Sci. 2014 Jan; 59(1):135-45. PMID: 24091907.
      View in: PubMed
    40. Sheibani S, Mahadevan U. Editorial: Are thiopurines and anti-TNFa agents safe to use in pregnant patients with inflammatory bowel disease? Am J Gastroenterol. 2013 Mar; 108(3):441-3. PMID: 23459048.
      View in: PubMed
    41. Ng SW, Mahadevan U. Management of inflammatory bowel disease in pregnancy. Expert Rev Clin Immunol. 2013 Feb; 9(2):161-73; quiz 174. PMID: 23390947.
      View in: PubMed
    42. Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Jan; 19(1):15-22. PMID: 22434610.
      View in: PubMed
    43. Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, Ullman T, Glover S, Valentine JF, Rubin DT, Miller J, Abreu MT. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013 Mar; 11(3):286-92; quiz e24. PMID: 23200982; PMCID: PMC3913646.
    44. Pak S, Holland N, Garnett EA, Mileti E, Mahadevan U, Beckert R, Kanwar B, Heyman MB. Cytokine profiles in peripheral blood of children and adults with Crohn disease. J Pediatr Gastroenterol Nutr. 2012 Jun; 54(6):769-75. PMID: 22167015; PMCID: PMC3339044.
    45. Hwang C, Ross V, Mahadevan U. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. Inflamm Bowel Dis. 2012 Oct; 18(10):1961-81. PMID: 22488830.
      View in: PubMed
    46. Esteve M, Mahadevan U, Sainz E, Rodriguez E, Salas A, Fernández-Bañares F. Efficacy of anti-TNF therapies in refractory severe microscopic colitis. J Crohns Colitis. 2011 Dec; 5(6):612-8. PMID: 22115383.
      View in: PubMed
    47. Leung Y, Heyman MB, Mahadevan U. Transitioning the adolescent inflammatory bowel disease patient: guidelines for the adult and pediatric gastroenterologist. Inflamm Bowel Dis. 2011 Oct; 17(10):2169-73. PMID: 21910179; PMCID: PMC3320668.
    48. Mahadevan U, Cucchiara S, Hyams JS, Steinwurz F, Nuti F, Travis SP, Sandborn WJ, Colombel JF. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol. 2011 Feb; 106(2):214-23; quiz 224. PMID: 21157441.
      View in: PubMed
    49. Broadhurst MJ, Leung JM, Kashyap V, McCune JM, Mahadevan U, McKerrow JH, Loke P. IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient. Sci Transl Med. 2010 Dec 01; 2(60):60ra88. PMID: 21123809.
      View in: PubMed
    50. van der Woude CJ, Kolacek S, Dotan I, Oresland T, Vermeire S, Munkholm P, Mahadevan U, Mackillop L, Dignass A. European evidenced-based consensus on reproduction in inflammatory bowel disease. J Crohns Colitis. 2010 Nov; 4(5):493-510. PMID: 21122553.
      View in: PubMed
    51. Kwan LY, Mahadevan U. Inflammatory bowel disease and pregnancy: an update. Expert Rev Clin Immunol. 2010 Jul; 6(4):643-57. PMID: 20594137.
      View in: PubMed
    52. Hou JK, Velayos F, Terrault N, Mahadevan U. Viral hepatitis and inflammatory bowel disease. Inflamm Bowel Dis. 2010 Jun; 16(6):925-32. PMID: 20480515.
      View in: PubMed
    53. Dotan I, Rachmilewitz D, Schreiber S, Eliakim R, van der Woude CJ, Kornbluth A, Buchman AL, Bar-Meir S, Bokemeyer B, Goldin E, Maaser C, Mahadevan U, Seidler U, Hoffman JC, Homoky D, Plasse T, Powers B, Rutgeerts P, Hommes D. A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease. Gut. 2010 Jun; 59(6):760-6. PMID: 20551461.
      View in: PubMed
    54. El-Nachef N, Terdiman J, Mahadevan U. Anti-tumor necrosis factor therapy for inflammatory bowel disease in the setting of immunosuppression for solid organ transplantation. Am J Gastroenterol. 2010 May; 105(5):1210-1. PMID: 20445523.
      View in: PubMed
    55. Baumgart DC, Targan SR, Dignass AU, Mayer L, van Assche G, Hommes DW, Hanauer SB, Mahadevan U, Reinisch W, Plevy SE, Salzberg BA, Buchman AL, Mechkov GM, Krastev ZA, Lowder JN, Frankel MB, Sandborn WJ. Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis. Inflamm Bowel Dis. 2010 Apr; 16(4):620-9. PMID: 19714757.
      View in: PubMed
    56. Molloy JW, Kim E, Mahadevan U. Do side-by-side anastomoses decrease the risk of recurrence in Crohn's disease? Gastroenterology. 2010 May; 138(5):2010-2. PMID: 20303965.
      View in: PubMed
    57. Sandborn WJ, Korzenik J, Lashner B, Leighton JA, Mahadevan U, Marion JF, Safdi M, Sninsky CA, Patel RM, Friedenberg KA, Dunnmon P, Ramsey D, Kane S. Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis. Gastroenterology. 2010 Apr; 138(4):1286-96, 1296.e1-3. PMID: 20064514.
      View in: PubMed
    58. Mahadevan U, Kane S. Use of infliximab in pregnancy. Am J Gastroenterol. 2010 Jan; 105(1):219; author reply 219-20. PMID: 20054309.
      View in: PubMed
    59. Mahadevan U. Pregnancy and inflammatory bowel disease. Med Clin North Am. 2010 Jan; 94(1):53-73. PMID: 19944798.
      View in: PubMed
    60. Mahadevan U. Pregnancy and inflammatory bowel disease. Gastroenterol Clin North Am. 2009 Dec; 38(4):629-49. PMID: 19913206.
      View in: PubMed
    61. Sewell JL, Mahadevan U. Of blemishes and bowels: isotretinoin and inflammatory bowel disease. Gastroenterology. 2010 Jan; 138(1):392-4. PMID: 19932213.
      View in: PubMed
    62. Mahadevan U. Cervical neoplasia risk in IBD: truth or hysteria? Inflamm Bowel Dis. 2009 Nov; 15(11):1619-20. PMID: 19408322.
      View in: PubMed
    63. Moscandrew M, Mahadevan U, Kane S. General health maintenance in IBD. Inflamm Bowel Dis. 2009 Sep; 15(9):1399-409. PMID: 19591135.
      View in: PubMed
    64. McCabe JM, Mahadevan U, Vidyarthi A. An obscure harbinger. Difficult diagnosis of Crohn's Disease. Am J Med. 2009 Jun; 122(6):516-8. PMID: 19486711.
      View in: PubMed
    65. Sewell JL, Mahadevan U. A new answer to an old question: azathioprine withdrawal in quiescent Crohn's disease. Gastroenterology. 2009 Jul; 137(1):379-81. PMID: 19482103.
      View in: PubMed
    66. Hou JK, Mahadevan U. A 24-year-old pregnant woman with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2009 Sep; 7(9):944-7. PMID: 19410016.
      View in: PubMed
    67. Costouros NG, Niho H, Mahadevan U, Kerlan RK, Bloom AI. Angiographic embolization for control of life-threatening hemorrhage from benign rectal ulcers. J Vasc Interv Radiol. 2009 Apr; 20(4):561-2. PMID: 19246210.
      View in: PubMed
    68. Thia KT, Mahadevan U, Feagan BG, Wong C, Cockeram A, Bitton A, Bernstein CN, Sandborn WJ. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2009 Jan; 15(1):17-24. PMID: 18668682.
      View in: PubMed
    69. Sewell JL, Mahadevan U. Infliximab and surgical complications: truth or perception? Gastroenterology. 2009 Jan; 136(1):354-5. PMID: 19059260.
      View in: PubMed
    70. Dubinsky M, Abraham B, Mahadevan U. Management of the pregnant IBD patient. Inflamm Bowel Dis. 2008 Dec; 14(12):1736-50. PMID: 18626967.
      View in: PubMed
    71. Mahadevan U. Continuing immunomodulators and biologic medications in pregnant IBD patients - pro. Inflamm Bowel Dis. 2007 Nov; 13(11):1439-40. PMID: 17763475.
      View in: PubMed
    72. Plevy S, Salzberg B, Van Assche G, Regueiro M, Hommes D, Sandborn W, Hanauer S, Targan S, Mayer L, Mahadevan U, Frankel M, Lowder J. A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis. Gastroenterology. 2007 Nov; 133(5):1414-22. PMID: 17920064.
      View in: PubMed
    73. Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology. 2007 Oct; 133(4):1106-12. PMID: 17764676.
      View in: PubMed
    74. Velayos F, Mahadevan U. Management of steroid-dependent ulcerative colitis: immunomodulatory agents, biologics, or surgery? Clin Gastroenterol Hepatol. 2007 Jun; 5(6):668-71. PMID: 17544992.
      View in: PubMed
    75. Mahadevan U. TNF-alpha antagonists: benefits beyond remission. Rev Gastroenterol Disord. 2007; 7 Suppl 1:S13-9. PMID: 17392633.
      View in: PubMed
    76. Mahadevan U. Gastrointestinal medications in pregnancy. Best Pract Res Clin Gastroenterol. 2007; 21(5):849-77. PMID: 17889812.
      View in: PubMed
    77. Mahadevan U. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut. 2006 Aug; 55(8):1198-206. PMID: 16849349; PMCID: PMC1856272.
    78. Mahadevan U, Kane S. American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006 Jul; 131(1):283-311. PMID: 16831611.
      View in: PubMed
    79. Mahadevan U, Kane S. American gastroenterological association institute medical position statement on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006 Jul; 131(1):278-82. PMID: 16831610.
      View in: PubMed
    80. Mahadevan U. Pregnancy, Fertility, and Therapies for IBD. Gastroenterol Hepatol (N Y). 2006 Apr; 2(4):234-236. PMID: 28286451.
      View in: PubMed
    81. Mahadevan U. Mucosal healing in Crohn's disease: what you see is what you get? Gastrointest Endosc. 2006 Mar; 63(3):443-4. PMID: 16500393.
      View in: PubMed
    82. Mahadevan U, Terdiman JP, Aron J, Jacobsohn S, Turek P. Infliximab and semen quality in men with inflammatory bowel disease. Inflamm Bowel Dis. 2005 Apr; 11(4):395-9. PMID: 15803031.
      View in: PubMed
    83. Gill KR, Mahadevan U. Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease. Inflamm Bowel Dis. 2005 Feb; 11(2):210-2. PMID: 15677920.
      View in: PubMed
    84. Mahadevan U. Medical treatment of ulcerative colitis. Clin Colon Rectal Surg. 2004 Feb; 17(1):7-19. PMID: 20011280; PMCID: PMC2780076.
    85. Mahadevan U. 6TG: when less is more than you bargained for. Inflamm Bowel Dis. 2003 Nov; 9(6):394-5. PMID: 14677541.
      View in: PubMed
    86. Mathy C, Schneider K, Chen YY, Varma M, Terdiman JP, Mahadevan U. Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis. Inflamm Bowel Dis. 2003 Nov; 9(6):351-5. PMID: 14671483.
      View in: PubMed
    87. Mahadevan U, Sandborn WJ. Diagnosis and management of pouchitis. Gastroenterology. 2003 May; 124(6):1636-50. PMID: 12761722.
      View in: PubMed
    88. Mahadevan U, Loftus EV, Tremaine WJ, Pemberton JH, Harmsen WS, Schleck CD, Zinsmeister AR, Sandborn WJ. Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications. Inflamm Bowel Dis. 2002 Sep; 8(5):311-6. PMID: 12479645.
      View in: PubMed
    89. Mahadevan U, Loftus EV, Tremaine WJ, Sandborn WJ. Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease. Am J Gastroenterol. 2002 Apr; 97(4):910-4. PMID: 12008668.
      View in: PubMed